Filing Details

Accession Number:
0001317757-10-000023
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-08-23 16:29:20
Reporting Period:
2010-08-20
Filing Date:
2010-08-23
Accepted Time:
2010-08-23 16:29:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
792977 Amag Pharmaceuticals Inc. AMAG In Vitro & In Vivo Diagnostic Substances (2835) 042742593
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1408474 Phd Md F Lee Allen C/O Amag Pharmaceuticals, Inc.
100 Hayden Avenue
Lexington MA 02421
Chief Medical Officer And Evp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-08-20 13,750 $0.00 1,912 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading pan adopted by the reporting person.
  2. The shares sold on this date were sold in multiple transactions. The price is the weighted average sales price per share of all shares sold on this day. The actual sales prices range from $27.878-$28.71. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.